RenovoRx, Inc.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath …
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
RenovoRx, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
RenovoRx, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of RenovoRx, Inc..